Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iberogast in Irritable Bowel Syndrome
NCT01940848Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2013
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Iberogast in irritable bowel syndrome (IBS), sponsored by Bayer. Started Oct 2013; status: completed.
02
Drugs
Iberogast
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01940848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01940848.